selegiline hydrochloride

Generic: selegiline hydrochloride

Labeler: i3 pharmaceuticals, llc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name selegiline hydrochloride
Generic Name selegiline hydrochloride
Labeler i3 pharmaceuticals, llc
Dosage Form TABLET
Routes
ORAL
Active Ingredients

selegiline hydrochloride 5 mg/1

Manufacturer
i3 Pharmaceuticals, LLC

Identifiers & Regulatory

Product NDC 72319-006
Product ID 72319-006_248576e6-bc11-e847-e063-6294a90afe9d
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA074672
Listing Expiration 2026-12-31
Marketing Start 2021-12-15

Pharmacologic Class

Classes
monoamine oxidase inhibitor [epc] monoamine oxidase inhibitors [moa] monoamine oxidase type b inhibitor [epc] monoamine oxidase-b inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 72319006
Hyphenated Format 72319-006

Supplemental Identifiers

RxCUI
859193
UPC
0372319006029
UNII
6W731X367Q

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name selegiline hydrochloride (source: ndc)
Generic Name selegiline hydrochloride (source: ndc)
Application Number ANDA074672 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 5 mg/1
source: ndc
Packaging
  • 60 TABLET in 1 BOTTLE (72319-006-02)
source: ndc

Packages (1)

72319-006-02 60 TABLET in 1 BOTTLE (72319-006-02)

Ingredients (1)

selegiline hydrochloride (5 mg/1)

Linked Drug Pages (1)

Selegiline Hydrochloride ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "248576e6-bc11-e847-e063-6294a90afe9d", "openfda": {"upc": ["0372319006029"], "unii": ["6W731X367Q"], "rxcui": ["859193"], "spl_set_id": ["c81e983b-455d-2e65-e053-2a95a90a3123"], "manufacturer_name": ["i3 Pharmaceuticals, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "60 TABLET in 1 BOTTLE (72319-006-02)", "package_ndc": "72319-006-02", "marketing_start_date": "20211215"}], "brand_name": "Selegiline Hydrochloride", "product_id": "72319-006_248576e6-bc11-e847-e063-6294a90afe9d", "dosage_form": "TABLET", "pharm_class": ["Monoamine Oxidase Inhibitor [EPC]", "Monoamine Oxidase Inhibitors [MoA]", "Monoamine Oxidase Type B Inhibitor [EPC]", "Monoamine Oxidase-B Inhibitors [MoA]"], "product_ndc": "72319-006", "generic_name": "Selegiline Hydrochloride", "labeler_name": "i3 Pharmaceuticals, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Selegiline Hydrochloride", "active_ingredients": [{"name": "SELEGILINE HYDROCHLORIDE", "strength": "5 mg/1"}], "application_number": "ANDA074672", "marketing_category": "ANDA", "marketing_start_date": "20211215", "listing_expiration_date": "20261231"}